News
Type
link
|
|
Huzhou Hengyuan Biochem. Tech. Co., Ltd., founded in July, 2004, is located in the Changchao Chemistry Zone, Huzhou City, Zhejiang Province.It is on the borders of Zhejiang and Jiangsu provinces, west of Shanghai, which is the central region of the Yangtze River Delta Area. The company has convenient transportation, which is sitting close next to M318 highway and is surrounded by four highways connecting Shanghai, Suzhou, Hangzhou and Nanjing city. Covering an area of 14000 square meters, and refined clean surroundings.In 2008,it was evaluated “Zhejiang Scientific Minor Enterprise” by Zhejiang Province Science and Technology Bureau.
The company is concentrate on the development of new-style chemical medicine and have successfully developed over 10 kinds of products, such as duloxetine HCl, isoxepac, 5-Methylnicotinic acid, olopatadine hydrochloride, olopatadine hydrochloride, milrinone, azelnidipine, etc. Isoxepac, 5-Methylnicotinic acid and lornoxicam obtained Zhejiang Province High-technology Product, which have the stable markets at home and abroad, and the company develops new products frequently,and are mainly sold to europe, japan, korea and indonesia and other regions.
The company will continually improve its management and technology for higher quality and better service. Looking forward to old and new customers to visit, inspect and negotiate, the company sincerely hopes to work together on mutual benefits and to create a brilliant future.
You are welcome to contact with our cooperation, negotiation and sincerely hope to have the opportunity for your service. |
Company Name: |
Huzhou Hengyuan Biochem. Tech. Co., Ltd. |
Company type: |
Business units () |
Region: |
Zhejiang |
Company Size: |
|
Registered Capital: |
0万Yuan |
Registration time: |
2004 |
Certification: |
|
Business Scope: |
HCl, isoxepac, 5-Methylnicotinic acid, olopatadine hydrochloride, olopatadine hydrochloride, milrinone, azelnidipine, etc. Isoxepac, 5-Methylnicotinic acid and lornoxicam |
Industry: |
|
Contact information
|